Vaccine developer Bellicum adds to seed round
According to VentureWire Alert, Houston-based Bellicum Pharmaceuticals Inc. has raised $1.03 million as part of an ongoing seed round. That brings its total capital raised to almost $5 million. In October 2007, the cancer vaccine developer announced it had received $1.45 million from the State of Texas’ Emerging Technology Fund and an additional $2.3 million seed funding.
The company is located in the Greenway Plaza near downtown Houston. .:.
According to VentureWire Alert, Houston-based Bellicum Pharmaceuticals Inc. has raised $1.03 million as part of an ongoing seed round. That brings its total capital raised to almost $5 million. In October 2007, the cancer vaccine developer announced it had received $1.45 million from the State of Texas’ Emerging Technology Fund and an additional $2.3 million seed funding.
The company is located in the Greenway Plaza near downtown Houston. .:.
![U.S. Megas [America2050.org]](http://www.america2050.org//sync/elements/america2050map.png){kind=link}
0 Comments:
Post a Comment